Insider Trading - Patterson Matthew R

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Patterson Matthew R

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-07-12
Sale
2017-07-14
8:01 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
15,000 $20 $300,059 186,814
(Indirect)
View
2017-09-15
Sale
2017-09-19
6:00 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $25.06 $250,561 614,772
(Indirect
Direct)
View
2017-10-02
Sale
2017-10-04
8:25 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
25,000 $27.92 $698,070 371,564
(Indirect
Direct)
View
2018-04-02
Sale
2018-04-04
9:01 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
700 $30.01 $21,009 370,864
(Indirect
Direct)
View
2018-05-21
Sale
2018-05-23
6:13 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,300 $38.15 $774,498 350,564
(Indirect
Direct)
View
2018-07-02
Sale
2018-07-05
6:34 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
71,048 $39.55 $2,809,837 727,266
(Indirect
Direct)
View
2018-09-18
Sale
2018-09-20
7:01 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,952 $40 $518,080 300,159
(Indirect
Direct)
View
2018-10-01
Sale
2018-10-02
7:04 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $38.16 $801,372 258,516
(Indirect
Direct)
View
2019-02-25
Sale
2019-02-27
4:31 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $30 $630,000 429,562
(Indirect
Direct)
View
2019-08-12
Sale
2019-08-14
7:03 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,000 $34.04 $680,835 457,001
(Indirect
Direct)
View
2019-11-08
Sale
2019-11-12
5:32 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
14,426 $30 $432,780 440,601
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-01-25
Option Award
2017-01-27
6:09 pm
N/A
2027-01-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
200,000 $0 200,000
(Direct)
View
2017-09-15
Exercise
2017-09-19
6:00 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $0 614,772
(Direct)
View
2017-09-15
Exercise
2017-09-19
6:00 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $0.78 614,772
(Direct)
View
2017-10-02
Exercise
2017-10-04
8:25 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $0 371,564
(Direct)
View
2017-10-02
Exercise
2017-10-04
8:25 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $0.78 371,564
(Direct)
View
2017-11-16
Option Award
2017-11-17
5:07 pm
N/A
2027-11-16
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
225,000 $0 225,000
(Direct)
View
2018-03-27
Option Award
2018-03-29
7:27 pm
N/A
2028-03-27
Homology Medicines Inc. FIXX Patterson Matthew R
Director
8,360 $0 8,360
(Direct)
View
2018-04-02
Exercise
2018-04-04
9:01 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
700 $0 370,864
(Direct)
View
2018-04-02
Exercise
2018-04-04
9:01 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
700 $0.78 370,864
(Direct)
View
2018-05-21
Exercise
2018-05-23
6:13 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,300 $0 350,564
(Direct)
View
2018-05-21
Exercise
2018-05-23
6:13 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,300 $0.78 350,564
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
71,048 $0 727,266
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
71,048 $0.78 727,266
(Direct)
View
2018-09-18
Exercise
2018-09-20
7:01 pm
N/A
2025-02-04
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,952 $0 300,159
(Direct)
View
2018-09-18
Exercise
2018-09-20
7:01 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,952 $2.19 300,159
(Direct)
View
2018-09-24
Exercise
2018-09-24
6:12 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
15,000 $0 279,516
(Direct)
View
2018-09-24
Exercise
2018-09-24
6:12 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
15,000 $0.78 279,516
(Direct)
View
2018-10-01
Exercise
2018-10-02
7:04 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $0 258,516
(Direct)
View
2018-10-01
Exercise
2018-10-02
7:04 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $0.78 258,516
(Direct)
View
2018-12-06
Exercise
2018-12-10
4:39 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
40,000 $0 258,516
(Direct)
View
2018-12-06
Exercise
2018-12-10
4:39 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
40,000 $0.78 258,516
(Direct)
View
2019-02-06
Option Award
2019-02-08
5:50 pm
N/A
2029-02-06
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
241,150 $0 467,964
(Direct)
View
2019-02-25
Exercise
2019-02-27
4:31 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $0 429,562
(Direct)
View
2019-02-25
Exercise
2019-02-27
4:31 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
4,000 $2.19 429,562
(Direct)
View
2019-02-25
Exercise
2019-02-27
4:31 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
17,000 $0.78 429,562
(Direct)
View
2019-06-05
Tax Withholding
2019-06-07
4:41 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
3,332 $37.31 287,182
(Direct)
View
2019-06-06
Option Award
2019-06-10
5:10 pm
N/A
2029-06-06
Homology Medicines Inc. FIXX Patterson Matthew R
Director
15,580 $0 15,580
(Direct)
View
2019-08-12
Exercise
2019-08-14
7:03 pm
N/A
2025-12-18
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,000 $0 457,001
(Direct)
View
2019-08-12
Exercise
2019-08-14
7:03 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,000 $9.5 457,001
(Direct)
View
2019-09-05
Tax Withholding
2019-09-09
4:05 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,974 $31.02 285,208
(Direct)
View
2019-11-08
Exercise
2019-11-12
5:32 pm
N/A
2025-12-18
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
14,426 $0 440,601
(Direct)
View
2019-11-08
Exercise
2019-11-12
5:32 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
14,426 $9.5 440,601
(Direct)
View
2019-12-05
Tax Withholding
2019-12-09
5:16 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,974 $59.21 283,234
(Direct)
View
2019-12-26
Gift
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,500 $0 765,175
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
11,666 $15.26 765,175
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
162,538 $0 765,175
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
74,297 $2.19 765,175
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
64,751 $0.78 765,175
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
11,824 $9.5 765,175
(Direct)
View
2020-01-15
Disposition
2020-01-15
1:35 pm
N/A
2025-12-18
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
734,353 $0 0
(Direct)
View
2020-01-15
Equity Swap
2020-01-15
1:35 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
433,272 $60 0
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:27 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX Patterson Matthew R
Director
18,000 $0 18,000
(Direct)
View
2020-10-16
Other
2020-10-20
8:56 pm
N/A
N/A
5:01 Acquisition Corp. FVAM Patterson Matthew R
Director
30,000 $0 30,000
(Direct)
View
2021-02-05
Option Award
2021-02-09
5:16 pm
N/A
2031-02-04
Vor Biopharma Inc. VOR Patterson Matthew R
Director
16,900 $0 16,900
(Direct)
View
2021-06-17
Option Award
2021-06-22
5:40 pm
N/A
2031-06-17
Homology Medicines Inc. FIXX Patterson Matthew R
Director
18,000 $0 18,000
(Direct)
View